Patent ID: 7939086
Filing Date: 2011-05-10
Classification: A61K,A61P,C07K,C12N

Abstract:
1. A method for inducing a specific immune response in a living animal body comprising administering an isolated MVA-BN virus or a derivative thereof to the animal; wherein the MVA-BN virus or a derivative thereof is characterized by having the capability of reproductive replication in vitro in chicken embryo fibroblasts (CEF) and by being more attenuated than MVA-575 and MVA-572 in the human keratinocyte cell line HaCaT, in the human bone osteosarcoma cell line 143B, in the human cervix adenocarcinoma cell line HeLa, and in the human embryo kidney cell line 293; and wherein a specific immune response is generated in the animal against the MVA-BN virus or a derivative thereof.